SAM.gov listing
U.S. National Science Foundation (NSF) X-Labs Initiative
- Agency
- NATIONAL SCIENCE FOUNDATION.NATIONAL SCIENCE FOUNDATION.DIRECTORATE FOR TECHNOLOGY, INNOVATION, & PARTNERSHIPS
- NAICS
- NAICS 541715
- PSC
- PSC AJ12 — Product Service Code AJ12
- Set-aside
- No Set aside used
- Type
- Solicitation
- CaptureIQ category
- Research / University / Nonprofit
- Posted
- 2026-09-16T00:00:00+00:00
- Response deadline
- 2028-05-14T15:00:00-04:00
Why this matters
- Related active opportunities exist for this agency or NAICS.
Related federal terms
Market context
- Related active opportunities
- 4 on RFPCapture
Related Federal Opportunities
- The Therapeutic Role of Soluble Adenylyl Cyclase Inhibition in Ameliorating Inflammatory Vascular Remodeling in Pulmonary Arterial Hypertension · HEALTH AND HUMAN SERVICES, DEPARTMENT OF.NATIONAL INSTITUTES OF HEALTH.NATIONAL INSTITUTE OF HEALTH NIH-OD · due 2026-09-21
- Low Temperature Insulation · DEPT OF DEFENSE.DEPT OF THE NAVY.NAVAIR.NAVAIR NAWC WD.NAVAL AIR WARFARE CENTER · due 2025-12-23
- Sources Sought: Call For Technology Independent Verification &Validation (IV&V) 27-1: Spectrum Proof · DEPT OF DEFENSE.WASHINGTON HEADQUARTERS SERVICES (WHS).WASHINGTON HEADQUARTERS SERVICES · due 2026-08-10
- Precision Inertial Navigation & Positioning On an Integrated Tesseract (PINPOINT) · DEPT OF DEFENSE.DEFENSE ADVANCED RESEARCH PROJECTS AGENCY (DARPA).DEF ADVANCED RESEARCH PROJECTS AGCY · due 2026-09-25
Related intelligence
- NAICS 541715 market
- NATIONAL SCIENCE FOUNDATION.NATIONAL SCIENCE FOUNDATION.DIRECTORATE FOR TECHNOLOGY, INNOVATION, & PARTNERSHIPS
- The Therapeutic Role of Soluble Adenylyl Cyclase Inhibition in Ameliorating Inflammatory Vascular Remodeling in Pulmonary Arterial Hypertension
- PSC AJ12 — Product Service Code AJ12
- Government contracting proposal software
- 2026 Federal IT Opportunity Benchmark